Penny stock under Rs 60 hit a 20 per cent upper circuit as the Board is likely to announce bonus shares!

DSIJ Intelligence-1 / 23 Jul 2025/ Categories: Bonus and Spilt Shares, Penny Stocks, Trending

Penny stock under Rs 60 hit a 20 per cent upper circuit as the Board is likely to announce bonus shares!

The shares of the company saw a spurt in volume by more than 7.50 times on the BSE.

On Wednesday, shares of Hamps Bio Ltd hit a 20 per cent upper circuit to Rs 53.40 per share from its previous closing of Rs 44.50 per share. The stock has a 52-week high of Rs 107.20 per share and a 52-week low of Rs 34.21 per share. The shares of the company saw a spurt in volume by more than 7.50 times on the BSE.

The Hamps Bio Ltd. Board of Directors meeting on July 29, 2025, will address key financial and corporate governance matters, including crucial decisions regarding the company's capital structure. Specifically, the board will consider and approve an increase in the Authorised Share Capital of the Company, necessitating a consequential amendment to its Memorandum of Association. This action expands the maximum number of shares the company is legally permitted to issue. Furthermore, the directors will consider and evaluate the proposal for the issue of bonus Shares, which, if approved by members and other requisite authorities, would involve distributing additional shares to existing shareholders without any further cost, typically from accumulated profits.

DSIJ's ‘Penny Pick’ service provides research-backed penny stock recommendations below Rs. 100. If this interests you, download the service details here.

Incorporated in 2007, Hamps Bio Limited specialises in the pharmaceutical formulation and freeze-drying ingredient sectors. The company ethically markets and distributes a wide range of pharmaceutical formulations, including tablets, syrups, capsules, and injectables, sourced from WHO GMP-approved manufacturers. Additionally, through its FDFP (Freeze Dried and Frozen Products) vertical, operating under the brand "FzyEzy," Hamps Bio manufactures and distributes freeze-dried fruits, vegetables, herbs, and flowers, catering to both B2B and B2C markets, with significant export operations.

In FY25, the company reported net sales of Rs 6.67 crore and net profit of Rs 0.30 crore. The company has a market cap of Rs 23.26 crore. The shares of the company have a PE of 80x, an ROE of 5 per cent and an ROCE of 7 per cent. The stock is up by 56 per cent from its 52-week low of Rs 34.21 per share.

Disclaimer: The article is for informational purposes only and not investment advice.